Intrauterine Contraceptive Device Market

An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. This devices lasts for 5 to 8 years. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal.

Intrauterine Contraceptive Device Market contains market size and forecasts of Intrauterine Contraceptive Device in global, including the following market information:

Global Intrauterine Contraceptive Device Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Intrauterine Contraceptive Device Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Intrauterine Contraceptive Device companies in 2021 (%)

The global Intrauterine Contraceptive Device market was valued at 2124.5 million in 2021 and is projected to reach US$ 2466.1 million by 2028, at a CAGR of 2.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hormonal IUCD Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Intrauterine Contraceptive Device include Bayer HealthCare, Medisafe Distribution, Teva Pharmaceutical Industrie, Medicines360 and Pace Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Intrauterine Contraceptive Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Intrauterine Contraceptive Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intrauterine Contraceptive Device Market Segment Percentages, by Type, 2021 (%)

Hormonal IUCD

Copper IUCD

Global Intrauterine Contraceptive Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intrauterine Contraceptive Device Market Segment Percentages, by Application, 2021 (%)

Hospitals

Surgical Centers

Global Intrauterine Contraceptive Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Intrauterine Contraceptive Device Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Intrauterine Contraceptive Device revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Intrauterine Contraceptive Device revenues share in global market, 2021 (%)

Key companies Intrauterine Contraceptive Device sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Intrauterine Contraceptive Device sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bayer HealthCare

Medisafe Distribution

Teva Pharmaceutical Industrie

Medicines360

Pace Pharmaceuticals